{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T21:57:45Z","timestamp":1793051865223,"version":"4.5.0"},"reference-count":76,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2023,9]]},"DOI":"10.1016\/j.ejmech.2023.115534","type":"journal-article","created":{"date-parts":[[2023,5,29]],"date-time":"2023-05-29T11:19:49Z","timestamp":1685359189000},"page":"115534","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":39,"special_numbering":"C","title":["Tetrahydrobenzo[h]quinoline derivatives as a novel chemotype for dual antileishmanial-antimalarial activity graced with antitubercular activity: Design, synthesis and biological evaluation"],"prefix":"10.1016","volume":"257","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1016-8950","authenticated-orcid":false,"given":"Tamer M.","family":"Ibrahim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ghada","family":"Abada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcel","family":"Dammann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raed M.","family":"Maklad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wagdy M.","family":"Eldehna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rofaida","family":"Salem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marwa M.","family":"Abdelaziz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramadan A.","family":"El-domany","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adnan A.","family":"Bekhit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank M.","family":"Beockler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2023.115534_bib1","series-title":"Leishmaniasis - Fact Sheets","author":"World Health Organization","year":"2022"},{"key":"10.1016\/j.ejmech.2023.115534_bib2","first-page":"37","article-title":"Infectious diseases of poverty in children: a tale of two worlds","volume":"63","author":"Hansen","year":"2016","journal-title":"Pediatr. Clin."},{"key":"10.1016\/j.ejmech.2023.115534_bib3","series-title":"Global Leishmaniasis Surveillance: 2019-2020, a Baseline for the 2030 Roadmap","author":"World Health Organization","year":"2021"},{"key":"10.1016\/j.ejmech.2023.115534_bib4","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2020.112514","article-title":"Natural and synthetic coumarins as antileishmanial agents: a review","volume":"203","author":"Gon\u00e7alves","year":"2020","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2023.115534_bib5","doi-asserted-by":"crossref","first-page":"2325","DOI":"10.4155\/fmc-2018-0058","article-title":"Synthesis, molecular modeling and biological screening of some pyrazole derivatives as antileishmanial agents","volume":"10","author":"Bekhit","year":"2018","journal-title":"Future Med. Chem."},{"key":"10.1016\/j.ejmech.2023.115534_bib6","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.ejmech.2018.10.022","article-title":"Leishmania treatment and prevention: natural and synthesized drugs","volume":"160","author":"Bekhit","year":"2018","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2023.115534_bib7","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.02851","article-title":"Global distribution maps of the leishmaniases","volume":"3","author":"Pigott","year":"2014","journal-title":"Elife"},{"key":"10.1016\/j.ejmech.2023.115534_bib8","first-page":"267","article-title":"Human leishmaniases: epidemiology and public health aspects, World health statistics quarterly","volume":"45","author":"Desjeux","year":"1992","journal-title":"Rapp. Trimest. Stat. Sanit. Mond."},{"key":"10.1016\/j.ejmech.2023.115534_bib9","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.4155\/fmc-2017-0120","article-title":"Synthesis, modeling and biological evaluation of hybrids from pyrazolo[1,5c]pyrimidine as antileishmanial agents","volume":"9","author":"Atta","year":"2017","journal-title":"Future Med. Chem."},{"key":"10.1016\/j.ejmech.2023.115534_bib10","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1021\/jacs.7b08729","article-title":"Large converse piezoelectric effect measured on a single molecule on a metallic surface","volume":"140","author":"Stetsovych","year":"2018","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.ejmech.2023.115534_bib11","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0062906","article-title":"The open access malaria box: a drug discovery catalyst for neglected diseases","volume":"8","author":"Spangenberg","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.ejmech.2023.115534_bib12","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2021.104772","article-title":"Molecular designing, crystal structure determination and in silico screening of copper(II) complexes bearing 8-hydroxyquinoline derivatives as anti-COVID-19","volume":"110","author":"Ali","year":"2021","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2023.115534_bib13","article-title":"Direct inhibitors of InhA are active against","volume":"7","author":"Manjunatha","year":"2015","journal-title":"Mycobact. Tubercul. Sci.Translat. Med."},{"key":"10.1016\/j.ejmech.2023.115534_bib14","doi-asserted-by":"crossref","first-page":"5177","DOI":"10.1007\/s11696-022-02243-8","article-title":"Exploiting the biological potential of Zn(II) complex derived from zwitterionic Schiff base: DNA binding and cytotoxicity activity against human cervical cancer","volume":"76","author":"Kamaal","year":"2022","journal-title":"Chem. Pap."},{"key":"10.1016\/j.ejmech.2023.115534_bib15","first-page":"1","article-title":"Prevalence of malaria and associated factors in Dilla town and the surrounding rural areas, Gedeo Zone, Southern Ethiopia","volume":"6","author":"Molla","year":"2015","journal-title":"J. Bacteriol. Parasitol."},{"key":"10.1016\/j.ejmech.2023.115534_bib16","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1111\/j.1472-8206.2009.00709.x","article-title":"Current status of malaria chemotherapy and the role of pharmacology in antimalarial drug research and development","volume":"23","author":"Na-Bangchang","year":"2009","journal-title":"Fund. Clin. Pharmacol."},{"key":"10.1016\/j.ejmech.2023.115534_bib17","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.ejmech.2018.11.067","article-title":"Synthesis, in silico experiments and biological evaluation of 1,3,4-trisubstituted pyrazole derivatives as antimalarial agents","volume":"163","author":"Bekhit","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2023.115534_bib18","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1042\/bse0510063","article-title":"Folate metabolic pathways in Leishmania","volume":"51","author":"Vickers","year":"2011","journal-title":"Essays Biochem."},{"key":"10.1016\/j.ejmech.2023.115534_bib19","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.molbiopara.2013.02.008","article-title":"Folate metabolism in human malaria parasites--75 years on","volume":"188","author":"M\u00fcller","year":"2013","journal-title":"Mol. Biochem. Parasitol."},{"key":"10.1016\/j.ejmech.2023.115534_bib20","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1016\/j.drudis.2015.04.006","article-title":"Potential therapeutic targets and the role of technology in developing novel antileishmanial drugs","volume":"20","author":"Rajasekaran","year":"2015","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.ejmech.2023.115534_bib21","doi-asserted-by":"crossref","first-page":"13883","DOI":"10.1074\/jbc.272.21.13883","article-title":"The roles of pteridine reductase 1 and dihydrofolate reductase-thymidylate synthase in pteridine metabolism in the protozoan parasite Leishmania major","volume":"272","author":"Nare","year":"1997","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejmech.2023.115534_bib22","doi-asserted-by":"crossref","first-page":"8318","DOI":"10.1021\/jm300563f","article-title":"Structure-based selectivity optimization of piperidine\u2013pteridine derivatives as potent Leishmania pteridine reductase inhibitors","volume":"55","author":"Corona","year":"2012","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2023.115534_bib23","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1007\/s00894-011-1187-0","article-title":"3D-QSAR based pharmacophore modeling and virtual screening for identification of novel pteridine reductase inhibitors","volume":"18","author":"Dube","year":"2012","journal-title":"J. Mol. Model."},{"key":"10.1016\/j.ejmech.2023.115534_bib24","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.exppara.2015.12.009","article-title":"Molecular characterization and functional analysis of pteridine reductase in wild-type and antimony-resistant Leishmania lines","volume":"160","author":"de Souza Moreira","year":"2016","journal-title":"Exp. Parasitol."},{"key":"10.1016\/j.ejmech.2023.115534_bib25","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/j.ejmech.2017.03.043","article-title":"An integrated approach towards the discovery of novel non-nucleoside Leishmania major pteridine reductase 1 inhibitors","volume":"132","author":"Leite","year":"2017","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2023.115534_bib26","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.ejmech.2019.06.051","article-title":"Synthesis, in vitro biological evaluation and in silico studies of certain arylnicotinic acids conjugated with aryl (thio) semicarbazides as a novel class of anti-leishmanial agents","volume":"179","author":"Eldehna","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2023.115534_bib27","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.ejmech.2015.10.008","article-title":"Structure activity relationships of 4-hydroxy-2-pyridones: a novel class of antituberculosis agents","volume":"106","author":"Ng","year":"2015","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2023.115534_bib28","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.ejmech.2017.12.038","article-title":"Design, synthesis and biological evaluations of novel pyridone-thiazole hybrid molecules as antitumor agents","volume":"145","author":"Xie","year":"2018","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2023.115534_bib29","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1039\/c0md00009d","article-title":"Synthesis and biological activity of new pyridone diaryl ether non-nucleoside inhibitors of HIV-1 reverse transcriptase","volume":"1","author":"Kennedy-Smith","year":"2010","journal-title":"MedChemComm"},{"key":"10.1016\/j.ejmech.2023.115534_bib30","first-page":"92","article-title":"A convenient synthesis of cyclopenta[b]pyridin-2,5-dione as a non- glycosidic cardiotonic agent","author":"Robert","year":"2008","journal-title":"ARKIVOC (Gainesville, FL, U. S.)"},{"key":"10.1016\/j.ejmech.2023.115534_bib31","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/j.ejmech.2014.07.052","article-title":"Design, synthesis, antimicrobial evaluation and molecular docking studies of some new thiophene, pyrazole and pyridone derivatives bearing sulfisoxazole moiety","volume":"84","author":"Nasr","year":"2014","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2023.115534_bib32","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1021\/jm901237x","article-title":"Design, synthesis, and antihepatitis B virus activities of novel 2-pyridone derivatives","volume":"53","author":"Lv","year":"2010","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2023.115534_bib33","doi-asserted-by":"crossref","first-page":"4694","DOI":"10.1016\/j.bmc.2010.05.023","article-title":"Synthesis and antiplasmodial activity of lycorine derivatives","volume":"18","author":"Cedr\u00f3n","year":"2010","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2023.115534_bib34","doi-asserted-by":"crossref","first-page":"818","DOI":"10.3923\/ijp.2017.818.831","article-title":"Quinazolinone derivatives as a potential class of compounds in malaria drug discovery","volume":"13","author":"Bule","year":"2017","journal-title":"Int. J. Pharmacol."},{"key":"10.1016\/j.ejmech.2023.115534_bib35","doi-asserted-by":"crossref","first-page":"4247","DOI":"10.2147\/DDDT.S224561","article-title":"Small-molecule intervention at the dimerization interface of survivin by novel rigidized scaffolds","volume":"13","author":"Ibrahim","year":"2019","journal-title":"Drug Des. Dev. Ther."},{"key":"10.1016\/j.ejmech.2023.115534_bib36","doi-asserted-by":"crossref","first-page":"8318","DOI":"10.1021\/jm300563f","article-title":"Structure-based selectivity optimization of piperidine\u2013pteridine derivatives as potent leishmania pteridine reductase inhibitors","volume":"55","author":"Corona","year":"2012","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2023.115534_bib37","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/S0014-827X(99)00004-X","article-title":"Synthesis of 4-alkyl (aryl)-6-aryl-3-cyano-2(1H)-pyridinones and their 2-imino isosteres as nonsteroidal cardiotonic agents","volume":"54","author":"Abadi","year":"1999","journal-title":"Farmaco (Societa chimica italiana : 1989)"},{"key":"10.1016\/j.ejmech.2023.115534_bib38","doi-asserted-by":"crossref","first-page":"5974","DOI":"10.1016\/j.bmc.2009.06.063","article-title":"Design, synthesis and biological evaluation of novel pyridine derivatives as anticancer agents and phosphodiesterase 3 inhibitors","volume":"17","author":"Abadi","year":"2009","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2023.115534_bib39","doi-asserted-by":"crossref","first-page":"3574","DOI":"10.1016\/j.bmcl.2006.03.085","article-title":"Development of sulfonamide compounds as potent methionine aminopeptidase type II inhibitors with antiproliferative properties","volume":"16","author":"Kawai","year":"2006","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2023.115534_bib40","doi-asserted-by":"crossref","first-page":"9564","DOI":"10.1039\/C5OB01463H","article-title":"Dicyanovinyl-substituted J147 analogue inhibits oligomerization and fibrillation of \u03b2-amyloid peptides and protects neuronal cells from \u03b2-amyloid-induced cytotoxicity","volume":"13","author":"Kim","year":"2015","journal-title":"Org. Biomol. Chem."},{"key":"10.1016\/j.ejmech.2023.115534_bib41","doi-asserted-by":"crossref","first-page":"14540","DOI":"10.1021\/acs.jmedchem.1c01059","article-title":"Discovery of EEDi-5273 as an exceptionally potent and orally efficacious EED inhibitor capable of achieving complete and persistent tumor regression","volume":"64","author":"Rej","year":"2021","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2023.115534_bib42","doi-asserted-by":"crossref","first-page":"4397","DOI":"10.1021\/ja00063a082","article-title":"1-Hydroxy-7-azabenzotriazole. An efficient peptide coupling additive","volume":"115","author":"Carpino","year":"1993","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.ejmech.2023.115534_bib43","doi-asserted-by":"crossref","DOI":"10.1016\/j.compbiomed.2020.104156","article-title":"Mechanistic insight on the remdesivir binding to RNA-Dependent RNA polymerase (RdRp) of SARS-cov-2","volume":"129","author":"Arba","year":"2021","journal-title":"Comput. Biol. Med."},{"key":"10.1016\/j.ejmech.2023.115534_bib44","doi-asserted-by":"crossref","DOI":"10.1016\/j.compbiomed.2021.104295","article-title":"Targeting multiple conformations of SARS-CoV2 Papain-Like Protease for drug repositioning: an in-silico study","volume":"131","author":"Ismail","year":"2021","journal-title":"Comput. Biol. Med."},{"key":"10.1016\/j.ejmech.2023.115534_bib45","doi-asserted-by":"crossref","first-page":"6306","DOI":"10.1080\/07391102.2020.1796811","article-title":"Targeting SARS-CoV-2 spike protein of COVID-19 with naturally occurring phytochemicals: an in silico study for drug development","volume":"39","author":"Pandey","year":"2021","journal-title":"J. Biomol. Struct. Dyn."},{"key":"10.1016\/j.ejmech.2023.115534_bib46","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1007\/s00109-020-01980-1","article-title":"Insights into the biased activity of dextromethorphan and haloperidol towards SARS-CoV-2 NSP6: in silico binding mechanistic analysis","volume":"98","author":"Pandey","year":"2020","journal-title":"J. Mol. Med."},{"key":"10.1016\/j.ejmech.2023.115534_bib47","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/srep42717","article-title":"SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules","volume":"7","author":"Daina","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejmech.2023.115534_bib48","doi-asserted-by":"crossref","first-page":"2615","DOI":"10.1021\/jm020017n","article-title":"Molecular properties that influence the oral bioavailability of drug candidates","volume":"45","author":"Veber","year":"2002","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2023.115534_bib49","doi-asserted-by":"crossref","first-page":"2719","DOI":"10.1021\/jm901137j","article-title":"New substructure filters for removal of pan assay interference compounds (PAINS) from screening libraries and for their exclusion in bioassays","volume":"53","author":"Baell","year":"2010","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2023.115534_bib50","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1038\/nrd1416","article-title":"Antimalarial drug discovery: efficacy models for compound screening","volume":"3","author":"Fidock","year":"2004","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ejmech.2023.115534_bib51","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1126\/science.781840","article-title":"Human malaria parasites in continuous culture","volume":"193","author":"Trager","year":"1976","journal-title":"Science (New York, N.Y.)"},{"key":"10.1016\/j.ejmech.2023.115534_bib52","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1128\/AAC.41.5.1004","article-title":"Microplate alamar blue assay versus BACTEC 460 system for high-throughput screening of compounds against","volume":"41","author":"Collins","year":"1997","journal-title":"Mycobact. Tubercul. Mycobact. Avium, Antimicrob.Agents Chemother."},{"key":"10.1016\/j.ejmech.2023.115534_bib53","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1080\/14756366.2017.1410480","article-title":"Benzimidazole derivatives endowed with potent antileishmanial activity","volume":"33","author":"Tonelli","year":"2018","journal-title":"J. Enzym. Inhib. Med. Chem."},{"key":"10.1016\/j.ejmech.2023.115534_bib54","doi-asserted-by":"crossref","first-page":"69","DOI":"10.3109\/14756366.2011.575071","article-title":"Synthesis and biological screening of some pyridine derivatives as anti-malarial agents","volume":"27","author":"Bekhit","year":"2012","journal-title":"J. Enzym. Inhib. Med. Chem."},{"key":"10.1016\/j.ejmech.2023.115534_bib55","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1016\/0223-5234(94)90193-7","article-title":"Antiinflammatory activity of novel indole derivatives","volume":"29","author":"Verma","year":"1994","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2023.115534_bib56","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.saa.2014.05.013","article-title":"Synthesis, characterization and spectroscopic behavior of novel 2-oxo-1,4-disubstituted-1,2,5,6-tetrahydrobenzo[h]quinoline-3-carbonitrile dyes","volume":"133","author":"Khan","year":"2014","journal-title":"Spectrochim. Acta Mol. Biomol. Spectrosc."},{"key":"10.1016\/j.ejmech.2023.115534_bib57","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1007\/s12039-011-0184-2","article-title":"Synthesis of some new 2-oxo-1,4-disubstituted-1,2,5,6-tetrahydro-benzo[h]quinoline-3-carbonitriles and their biological evaluation as cytotoxic and antiviral agents","volume":"124","author":"Faidallah","year":"2012","journal-title":"J. Chem. Sci."},{"key":"10.1016\/j.ejmech.2023.115534_bib58","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1002\/jhet.112","article-title":"An efficient synthesis of indeno[1,2-b]pyridine and benzo[h]quinoline derivatives under solvent-free conditions","volume":"46","author":"Rong","year":"2009","journal-title":"J. Heterocycl. Chem."},{"key":"10.1016\/j.ejmech.2023.115534_bib59","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1080\/00397910802463878","article-title":"Efficient one-pot synthesis of 4-Aryl-3-cyano-2,5-dihydro-1H-indeno[1,2-b]pyridin-2-one and 4-Aryl-3-cyano-1,2,5,6-tetrahydrobenzo[h]quinolin-2-one derivatives under solvent-free conditions","volume":"39","author":"Rong","year":"2009","journal-title":"Synth. Commun."},{"key":"10.1016\/j.ejmech.2023.115534_bib60","doi-asserted-by":"crossref","first-page":"2783","DOI":"10.1016\/0960-894X(95)00487-E","article-title":"The anti-rheumatic potential of a series of 2,4-di-substituted-4H-naphtho[1,2-b]pyran-3-carbonitriles","volume":"5","author":"Smith","year":"1995","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2023.115534_bib61","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.jscs.2009.06.001","article-title":"One-pot multicomponent synthesis of some 5,6-dihydro-benzo[h]quinoline derivatives","volume":"13","author":"Al-Mutairi","year":"2009","journal-title":"J. Saudi Chem. Soc."},{"key":"10.1016\/j.ejmech.2023.115534_bib62","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1021\/jm00226a004","article-title":"Monoquaternary neuromuscular blocking agents based on 1-tetralone and 1-indanone","volume":"19","author":"Biggs","year":"1976","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2023.115534_bib63","series-title":"Vogel's Textbook of Practical Organic Chemistry","author":"Burniss","year":"1989"},{"key":"10.1016\/j.ejmech.2023.115534_bib64","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1038\/nsb921","article-title":"Insights into antifolate resistance from malarial DHFR-TS structures","volume":"10","author":"Yuvaniyama","year":"2003","journal-title":"Nat. Struct. Mol. Biol."},{"key":"10.1016\/j.ejmech.2023.115534_bib65","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1107\/S2053230X22002795","article-title":"Crystal structure of the ternary complex of Leishmania major pteridine reductase 1 with the cofactor NADP+\/NADPH and the substrate folic acid","volume":"78","author":"Dello Iacono","year":"2022","journal-title":"Acta Crystallogr. F"},{"key":"10.1016\/j.ejmech.2023.115534_bib66","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1021\/ci100436p","article-title":"FRED pose prediction and virtual screening accuracy","volume":"51","author":"McGann","year":"2011","journal-title":"J. Chem. Inf. Model."},{"key":"10.1016\/j.ejmech.2023.115534_bib67","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1007\/s10822-012-9584-8","article-title":"FRED and HYBRID docking performance on standardized datasets","volume":"26","author":"McGann","year":"2012","journal-title":"J. Comput. Aided Mol. Des."},{"key":"10.1016\/j.ejmech.2023.115534_bib68","doi-asserted-by":"crossref","first-page":"337","DOI":"10.3390\/cryst12030337","article-title":"Vibrational spectroscopy, quantum computational and molecular docking studies on 2-[(1H-Benzimidazol-1-yl)-methyl]benzoic acid","volume":"12","author":"Khanum","year":"2022","journal-title":"Crystals"},{"key":"10.1016\/j.ejmech.2023.115534_bib69","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1021\/ci100031x","article-title":"Conformer generation with OMEGA: algorithm and validation using high quality structures from the Protein Databank and Cambridge Structural Database","volume":"50","author":"Hawkins","year":"2010","journal-title":"J. Chem. Inf. Model."},{"key":"10.1016\/j.ejmech.2023.115534_bib76","unstructured":"Molecular Operating Environment MOE (version 2018), Chemical Computing Group Inc., Montreal, http:\/\/www.chemcomp\/com."},{"key":"10.1016\/j.ejmech.2023.115534_bib70","doi-asserted-by":"crossref","first-page":"2320","DOI":"10.1080\/14756366.2022.2117316","article-title":"New pyrazolylpyrazoline derivatives as dual acting antimalarial-antileishamanial agents: synthesis, biological evaluation and molecular modelling simulations","volume":"37","author":"Bekhit","year":"2022","journal-title":"J. Enzym. Inhib. Med. Chem."},{"key":"10.1016\/j.ejmech.2023.115534_bib71","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/j.ejmech.2018.04.003","article-title":"Anti-leishmanial click modifiable thiosemicarbazones: design, synthesis, biological evaluation and in silico studies","volume":"151","author":"Temraz","year":"2018","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2023.115534_bib72","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/j.ejmech.2014.12.051","article-title":"Antileishmanial activity of quinazoline derivatives: synthesis, docking screens, molecular dynamic simulations and electrochemical studies","volume":"92","author":"Mendoza-Mart\u00ednez","year":"2015","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2023.115534_bib73","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1016\/j.ejmech.2008.09.044","article-title":"Synthesis of chlorovinyl sulfones as structural analogs of chalcones and their antiplasmodial activities","volume":"44","author":"Dominguez","year":"2009","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2023.115534_bib74","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2022.105809","article-title":"Novel 2-arylthiazolidin-4-one-thiazole hybrids with potent activity against Mycobacterium tuberculosis","volume":"124","author":"Othman","year":"2022","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2023.115534_bib75","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1080\/14756366.2020.1868450","article-title":"Development of novel isatin-nicotinohydrazide hybrids with potent activity against susceptible\/resistant Mycobacterium tuberculosis and bronchitis causing-bacteria","volume":"36","author":"Elsayed","year":"2021","journal-title":"J. Enzym. Inhib. Med. Chem."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523423005007?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523423005007?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,7]],"date-time":"2024-11-07T09:53:21Z","timestamp":1730973201000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523423005007"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9]]},"references-count":76,"alternative-id":["S0223523423005007"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2023.115534","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2023,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Tetrahydrobenzo[h]quinoline derivatives as a novel chemotype for dual antileishmanial-antimalarial activity graced with antitubercular activity: Design, synthesis and biological evaluation","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2023.115534","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"115534"}}